Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1751 to 1800 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1751\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60 kda tat interactive protein (tip60) (hiv-1 tat interactive protein) (cpla(2) interacting protein). [source:swissprot;acc:q92993]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6011.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6414.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06711\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1752\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
copper-transporting atpase 1 (ec 3.6.3.4) (copper pump 1) (menkes disease-associated protein). [source:swissprot;acc:q04656]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5941.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6339.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0671\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1753\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 2 subunit 2 (eukaryotic translation initiation factor 2 beta subunit) (eif-2-beta). [source:swissprot;acc:p20042]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5423.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5787.46\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06707\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1754\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
copper-transporting atpase 2 (ec 3.6.3.4) (copper pump 2) (wilson disease-associated protein). [source:swissprot;acc:p35670]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5941.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6340.32\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1755\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromodomain y-like protein 2. [source:refseq;acc:nm\_152342]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7101.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7577.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06703\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1756\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s29. [source:swissprot;acc:p30054]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3582.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3357.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.067\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1757\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
testis-specific chromodomain y protein 1. [source:swissprot;acc:q9y6f8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7101.15\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7576.84\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06699\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1758\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromodomain protein, y chromosome-like isoform a; cdy-like, autosomal; testis-specific chromodomain y-like protein. [source:refseq;acc:nm\_004824]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1759\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
testis-specific chromodomain protein y protein 2. [source:swissprot;acc:q9y6f7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7101.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7576.87\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1760\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thioredoxin interacting protein; upregulated by 1,25-dihydroxyvitamin d-3. [source:refseq;acc:nm\_006472]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5693.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6075.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06698\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1761\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
electron transfer flavoprotein beta-subunit (beta-etf). [source:swissprot;acc:p38117]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7794.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8316.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06692\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1762\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor susceptibility gene 101 protein. [source:swissprot;acc:q99816]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6122.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6531.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06672\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1763\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dystrobrevin alpha (dystrobrevin-alpha). [source:swissprot;acc:q9y4j8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5829.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6218.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06668\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1764\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-1-syntrophin (59 kda dystrophin-associated protein a1, basic component 1) (dapa1b) (tax interaction protein 43) (tip-43) (syntrophin 2) (bsyn2). [source:swissprot;acc:q13884]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5829.61\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6218.27\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06667\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1765\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-2-syntrophin (59 kda dystrophin-associated protein a1, basic component 2) (syntrophin 3) (snt3) (syntrophin-like) (sntl). [source:swissprot;acc:q13425]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1766\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nitrilase 1. [source:refseq;acc:nm\_005600]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1767\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
utrophin (dystrophin-related protein 1) (drp1) (drp). [source:swissprot;acc:p46939]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1768\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial precursor (ec 2.3.1.-) (e2) (dihydrolipoamide branched chain transacylase) (bckad e2 subunit). [source:swissprot;acc:p11182]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1769\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dystrophin. [source:swissprot;acc:p11532]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1770\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
angiomotin. [source:refseq;acc:nm\_133265]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1771\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
angiomotin like 2; leman coiled-coil protein; angiomotin-like protein 2. [source:refseq;acc:nm\_016201]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1772\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-1-syntrophin (59 kda dystrophin-associated protein a1, acidic component 1) (pro-tgf-alpha cytoplasmic domain-interacting protein 1) (tacip1) (syntrophin 1). [source:swissprot;acc:q13424]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1773\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dystrobrevin beta (beta-dystrobrevin) (dtn-b). [source:swissprot;acc:o60941]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5829.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6218.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06666\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1774\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj470l14.3 (novel protein similar to the arp2/3 protein complex subunit p21-arc (arc21)). [source:sptrembl;acc:q9h5b6]\vspace{3pt}}&\multirow{13}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5386.37\vspace{3pt}}}&\multirow{13}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5744.89\vspace{3pt}}}&\multirow{13}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06656\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1775\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 258. [source:refseq;acc:nm\_145310]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1776\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 261 (dxs6673e protein). [source:swissprot;acc:q14202]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1777\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 262; cell death inhibiting rna. [source:refseq;acc:nm\_005095]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1778\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin-like protein 2 (actin-related protein 2). [source:swissprot;acc:o15142]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1779\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 3 (vesicle docking protein sec34 homolog) (p94). [source:swissprot;acc:q96jb2]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1780\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to actin-related protein 3-beta. [source:sptrembl;acc:q96bt2]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1781\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arp2/3 complex 41 kda subunit (p41-arc) (actin-related protein 2/3 complex subunit 1b). [source:swissprot;acc:o15143]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1782\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 198 (fused in myeloproliferative disorders protein) (rearranged in atypical myeloproliferative disorder protein). [source:swissprot;acc:q9ubw7]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1783\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin-like protein 3 (actin-related protein 3) (actin-2). [source:swissprot;acc:p32391]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1784\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arp2/3 complex 21 kda subunit (p21-arc) (actin-related protein 2/3 complex subunit 3). [source:swissprot;acc:o15145]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1785\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nardilysin precursor (ec 3.4.24.61) (n-arginine dibasic convertase) (nrd convertase) (nrd-c). [source:swissprot;acc:o43847]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1786\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin-related protein 2/3 complex subunit 1a (sop2-like protein). [source:swissprot;acc:q92747]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1787\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
interferon-related developmental regulator 2 (skmc15 protein). [source:swissprot;acc:q12894]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5386.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5744.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06652\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1788\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arp2/3 complex 16 kda subunit (p16-arc) (actin-related protein 2/3 complex subunit 5). [source:swissprot;acc:o15511]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5386.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5744.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06651\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1789\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein kinase 12 (ec 2.7.1.37) (aurora- and ipl1- like midbody-associated protein 1) (aim-1) (aurora/ipl1-related kinase 2) (aurora-related kinase 2) (stk-1) (aurora-b). [source:swissprot;acc:q96gd4]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5839.72\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6227.33\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06637\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1790\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin-like protein kif23 (mitotic kinesin-like protein-1) (kinesin- like protein 5). [source:swissprot;acc:q02241]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1791\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein kinase 13 (ec 2.7.1.37) (aurora/ipl1/eg2 protein 2) (aurora/ipl1-related kinase 3) (aurora-c). [source:swissprot;acc:q9uqb9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1792\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine kinase 6 (ec 2.7.1.37) (serine/threonine kinase 15) (aurora/ipl1-related kinase 1) (aurora-related kinase 1) (hark1) (aurora-a) (breast-tumor-amplified kinase). [source:swissprot;acc:o14965]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1793\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cylindromatosis (turban tumor syndrome); cylindromatosis 1, turban tumor syndrome. [source:refseq;acc:nm\_015247]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1794\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
epsin 2 isoform b; eps15 binding protein. [source:refseq;acc:nm\_014964]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5948.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6342.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06634\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1795\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerases iii 12.5 kda polypeptide (ec 2.7.7.6) (rna polymerase iii c11 subunit) (hsc11p) (hrpc11) (my010 protein). [source:swissprot;acc:q9y2y1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5501.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5866.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0663\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1796\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tubulin tyrosine ligase-like protein hottl (hqp0207). [source:swissprot;acc:q9y4r7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5387.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5743.5\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06605\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1797\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
valyl-trna synthetase 2 (ec 6.1.1.9) (valine--trna ligase 2) (valrs 2) (g7a). [source:swissprot;acc:p26640]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5096.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5432.63\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1798\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l32. [source:swissprot;acc:p02433]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3618.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3394.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06591\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1799\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b beta subunit (eif-2b gdp-gtp exchange factor) (s20i15) (s20iii15). [source:swissprot;acc:p49770]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5456.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5816.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0659\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1800\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b delta subunit (eif-2b gdp-gtp exchange factor). [source:swissprot;acc:q9ui10]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5424.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5781.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06587\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/